Federation des caisses Desjardins du Quebec
Position in BCYC — Bicycle Therapeutics PLC
CIK 2022297
LEVIS, A8
Position in BCYC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$66,361
-$34,896 QoQ
Shares Held
14,302
0.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Federation des caisses Desjardins du Quebec holds $43,674,244 across 135 Biotechnology names. BCYC ranks #31 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,252 | $7,148,462 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,955 | $7,124,544 | |
| 3 | ARGX |
Argenx SE
|
6,919 | $5,052,599 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,731 | $3,881,433 | |
| 5 | INCY |
Incyte Corp
|
31,446 | $2,959,696 | |
| 6 | TECH |
BIO-TECHNE Corp
|
38,673 | $2,021,050 | |
| 7 | MRNA |
Moderna, Inc.
|
37,887 | $1,924,658 | |
| 8 | INSM |
INSMED Inc
|
11,517 | $1,883,258 |
All Filings in BCYC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,361 | 14,302 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $101,257 | 14,302 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $110,697 | 14,302 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $66,739 | 9,603 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $517 | 61 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $854 | 61 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,380 | 61 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,234 | 61 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||